Cargando…

Development and validation of fear of hypoglycemia screener: results from the T1D exchange registry

BACKGROUND: Fear of Hypoglycemia (FoH) in people with diabetes has a significant impact on their quality of life, psychological well-being, and self-management of disease. There are a few questionnaires assessing FoH in people living with diabetes, but they are more often used in research than clini...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jingwen, Poon, Jiat-Ling, Bispham, Jeoffrey, Perez-Nieves, Magaly, Hughes, Allyson, Chapman, Katherine, Mitchell, Beth, Hood, Korey, Snoek, Frank, Fisher, Lawrence
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10169988/
https://www.ncbi.nlm.nih.gov/pubmed/37160500
http://dx.doi.org/10.1186/s41687-023-00585-9
_version_ 1785039148446384128
author Liu, Jingwen
Poon, Jiat-Ling
Bispham, Jeoffrey
Perez-Nieves, Magaly
Hughes, Allyson
Chapman, Katherine
Mitchell, Beth
Hood, Korey
Snoek, Frank
Fisher, Lawrence
author_facet Liu, Jingwen
Poon, Jiat-Ling
Bispham, Jeoffrey
Perez-Nieves, Magaly
Hughes, Allyson
Chapman, Katherine
Mitchell, Beth
Hood, Korey
Snoek, Frank
Fisher, Lawrence
author_sort Liu, Jingwen
collection PubMed
description BACKGROUND: Fear of Hypoglycemia (FoH) in people with diabetes has a significant impact on their quality of life, psychological well-being, and self-management of disease. There are a few questionnaires assessing FoH in people living with diabetes, but they are more often used in research than clinical practice. This study aimed to develop and validate a short and actionable FoH screener for adults living with type 1 diabetes (T1D) for use in routine clinical practice. METHODS: We developed an initial screener based on literature review and, interviews with healthcare providers (HCPs) and people with T1D. We developed a cross-sectional web-based survey, which was then conducted to examine the reliability and validity of the screener. Adults (aged ≥ 18 years) with diagnosis of T1D for ≥ 1 year were recruited from the T1D Exchange Registry (August–September 2020). The validation analyses were conducted using exploratory factor analyses, correlation, and multivariable regression models for predicting cut-off scores for the final screener. RESULTS: The final FoH screener comprised nine items assessing two domains, “worry” (6-items) and “avoidance behavior” (three items), in 592 participants. The FoH screener showed good internal consistency (Cronbach’s α = 0.88). The screener also demonstrated high correlations (r = 0.71–0.75) with the Hypoglycemia Fear Survey and moderate correlations with depression, anxiety, and diabetes distress scales (r = 0.44–0.66). Multivariable regression analysis showed that higher FoH screener scores were significantly associated with higher glycated hemoglobin (HbA1c) (b = 0.04) and number of comorbidities (b = 0.03). CONCLUSIONS: This short FoH screener demonstrated good reliability and validity. Further research is planned to assess clinical usability to identify patients with FoH and assist effective HCP-patient conversations. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s41687-023-00585-9.
format Online
Article
Text
id pubmed-10169988
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-101699882023-05-11 Development and validation of fear of hypoglycemia screener: results from the T1D exchange registry Liu, Jingwen Poon, Jiat-Ling Bispham, Jeoffrey Perez-Nieves, Magaly Hughes, Allyson Chapman, Katherine Mitchell, Beth Hood, Korey Snoek, Frank Fisher, Lawrence J Patient Rep Outcomes Research BACKGROUND: Fear of Hypoglycemia (FoH) in people with diabetes has a significant impact on their quality of life, psychological well-being, and self-management of disease. There are a few questionnaires assessing FoH in people living with diabetes, but they are more often used in research than clinical practice. This study aimed to develop and validate a short and actionable FoH screener for adults living with type 1 diabetes (T1D) for use in routine clinical practice. METHODS: We developed an initial screener based on literature review and, interviews with healthcare providers (HCPs) and people with T1D. We developed a cross-sectional web-based survey, which was then conducted to examine the reliability and validity of the screener. Adults (aged ≥ 18 years) with diagnosis of T1D for ≥ 1 year were recruited from the T1D Exchange Registry (August–September 2020). The validation analyses were conducted using exploratory factor analyses, correlation, and multivariable regression models for predicting cut-off scores for the final screener. RESULTS: The final FoH screener comprised nine items assessing two domains, “worry” (6-items) and “avoidance behavior” (three items), in 592 participants. The FoH screener showed good internal consistency (Cronbach’s α = 0.88). The screener also demonstrated high correlations (r = 0.71–0.75) with the Hypoglycemia Fear Survey and moderate correlations with depression, anxiety, and diabetes distress scales (r = 0.44–0.66). Multivariable regression analysis showed that higher FoH screener scores were significantly associated with higher glycated hemoglobin (HbA1c) (b = 0.04) and number of comorbidities (b = 0.03). CONCLUSIONS: This short FoH screener demonstrated good reliability and validity. Further research is planned to assess clinical usability to identify patients with FoH and assist effective HCP-patient conversations. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s41687-023-00585-9. Springer International Publishing 2023-05-09 /pmc/articles/PMC10169988/ /pubmed/37160500 http://dx.doi.org/10.1186/s41687-023-00585-9 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research
Liu, Jingwen
Poon, Jiat-Ling
Bispham, Jeoffrey
Perez-Nieves, Magaly
Hughes, Allyson
Chapman, Katherine
Mitchell, Beth
Hood, Korey
Snoek, Frank
Fisher, Lawrence
Development and validation of fear of hypoglycemia screener: results from the T1D exchange registry
title Development and validation of fear of hypoglycemia screener: results from the T1D exchange registry
title_full Development and validation of fear of hypoglycemia screener: results from the T1D exchange registry
title_fullStr Development and validation of fear of hypoglycemia screener: results from the T1D exchange registry
title_full_unstemmed Development and validation of fear of hypoglycemia screener: results from the T1D exchange registry
title_short Development and validation of fear of hypoglycemia screener: results from the T1D exchange registry
title_sort development and validation of fear of hypoglycemia screener: results from the t1d exchange registry
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10169988/
https://www.ncbi.nlm.nih.gov/pubmed/37160500
http://dx.doi.org/10.1186/s41687-023-00585-9
work_keys_str_mv AT liujingwen developmentandvalidationoffearofhypoglycemiascreenerresultsfromthet1dexchangeregistry
AT poonjiatling developmentandvalidationoffearofhypoglycemiascreenerresultsfromthet1dexchangeregistry
AT bisphamjeoffrey developmentandvalidationoffearofhypoglycemiascreenerresultsfromthet1dexchangeregistry
AT pereznievesmagaly developmentandvalidationoffearofhypoglycemiascreenerresultsfromthet1dexchangeregistry
AT hughesallyson developmentandvalidationoffearofhypoglycemiascreenerresultsfromthet1dexchangeregistry
AT chapmankatherine developmentandvalidationoffearofhypoglycemiascreenerresultsfromthet1dexchangeregistry
AT mitchellbeth developmentandvalidationoffearofhypoglycemiascreenerresultsfromthet1dexchangeregistry
AT hoodkorey developmentandvalidationoffearofhypoglycemiascreenerresultsfromthet1dexchangeregistry
AT snoekfrank developmentandvalidationoffearofhypoglycemiascreenerresultsfromthet1dexchangeregistry
AT fisherlawrence developmentandvalidationoffearofhypoglycemiascreenerresultsfromthet1dexchangeregistry